GLP-1 Weight Loss Drugs: What You Need to Know — From Real-World Effectiveness to New Oral Forms
GLP-1 medications (such as semaglutide and tirzepatide) have become one of the most remarkable advances in obesity treatment in recent years. According to Harvard Health, there are several important updates that anyone considering these medications should be aware of.
How These Medications Work
GLP-1 drugs work by mimicking a naturally occurring hormone in the body called glucagon-like peptide 1 (GLP-1). This hormone slows gastric emptying, helps regulate blood sugar, and reduces appetite — a combination that leads to weight loss. Some medications, such as tirzepatide (Zepbound), also mimic an additional hormone called GIP (glucose-dependent insulinotropic polypeptide), which is believed to enhance the effects of GLP-1, potentially leading to greater weight reduction.
The New Oral Formulation
A significant update: an oral tablet form of semaglutide for weight loss (Wegovy in pill form) became available in early January 2026 — offering a new option for people who cannot or prefer not to use injections. This development expands access and convenience for patients, potentially improving adherence to treatment.
Clinical Trial Efficacy vs. Real-World Results
In clinical trials, people using semaglutide or tirzepatide lost an average of 15% to 20% of their body weight. However, real-world effectiveness is typically only about half of what clinical trials report. The primary reason is that most users discontinue the medication prematurely, often due to a combination of factors including side effects, cost, and accessibility issues.
Side Effects and Long-Term Considerations
The most common side effects include nausea, vomiting, diarrhea, and constipation. Pancreatitis and gallbladder problems can also occur and may lead to serious health consequences. An important point to understand: to maintain the weight lost, patients typically need to continue taking the medication almost indefinitely — if the drug is stopped, weight regain is the expected outcome rather than an exception.
Cost Considerations
Initially, the average cost of these medications was around ,000 per month, though prices have been fluctuating and have decreased somewhat recently. Cost remains a significant barrier to long-term adherence for many patients, particularly in healthcare systems where these drugs are not fully covered by insurance.
What to Consider Before Starting
Given that real-world effectiveness is substantially lower than clinical trial results, combined with the requirement for long-term treatment and the significant cost involved, anyone considering GLP-1 medications for weight loss should have a thorough discussion with their healthcare provider about realistic treatment goals, the feasibility of long-term adherence, and potential side effects — rather than relying solely on the impressive numbers reported in clinical trials.
Helpful Products
As an Amazon Associate we earn from qualifying purchases.Source: Harvard Health Publishing
Related articles
